Correlation Between Exagen and Cns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Exagen and Cns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exagen and Cns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Exagen Inc and Cns Pharmaceuticals, you can compare the effects of market volatilities on Exagen and Cns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exagen with a short position of Cns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exagen and Cns Pharmaceuticals.
Diversification Opportunities for Exagen and Cns Pharmaceuticals
-0.54 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Exagen and Cns is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Exagen Inc and Cns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cns Pharmaceuticals and Exagen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exagen Inc are associated (or correlated) with Cns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cns Pharmaceuticals has no effect on the direction of Exagen i.e., Exagen and Cns Pharmaceuticals go up and down completely randomly.
Pair Corralation between Exagen and Cns Pharmaceuticals
Considering the 90-day investment horizon Exagen Inc is expected to under-perform the Cns Pharmaceuticals. In addition to that, Exagen is 2.11 times more volatile than Cns Pharmaceuticals. It trades about -0.06 of its total potential returns per unit of risk. Cns Pharmaceuticals is currently generating about 0.14 per unit of volatility. If you would invest 11.00 in Cns Pharmaceuticals on October 5, 2024 and sell it today you would earn a total of 1.30 from holding Cns Pharmaceuticals or generate 11.82% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Exagen Inc vs. Cns Pharmaceuticals
Performance |
Timeline |
Exagen Inc |
Cns Pharmaceuticals |
Exagen and Cns Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Exagen and Cns Pharmaceuticals
The main advantage of trading using opposite Exagen and Cns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exagen position performs unexpectedly, Cns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cns Pharmaceuticals will offset losses from the drop in Cns Pharmaceuticals' long position.Exagen vs. Fonar | Exagen vs. Burning Rock Biotech | Exagen vs. Sera Prognostics | Exagen vs. Castle Biosciences |
Cns Pharmaceuticals vs. ZyVersa Therapeutics | Cns Pharmaceuticals vs. Immix Biopharma | Cns Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | Cns Pharmaceuticals vs. Ocean Biomedical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
CEOs Directory Screen CEOs from public companies around the world | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |